Roswell Park Cancer Institute (RPCI) (founded 1898) is a cancer research and treatment center in Buffalo, New York founded by Dr. Roswell Park. Candace S. Johnson, PhD, is President & Chief Executive Officer of Roswell Park Cancer Institute. RPCI was the first dedicated medical facility for cancer treatment and research in the United States, and is the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center." The Institute, which conducts clinical research on cancer as well as developing new drugs, provides advanced treatment for all forms of adult and pediatric cancer and serves as a member of the National Comprehensive Cancer Network.The RPCI campus, spread out in 15 separate buildings of approximately two million sq ft, occupies 28 acres (11 ha) on the 100-acre (40 ha) Buffalo Niagara Medical Campus (BNMC) in downtown Buffalo, and includes 1,500,000 square feet (140,000 m²) of space equally distributed between clinical programs and research/education functions. A separate hospital building, completed in 1998, houses a diagnostic and treatment center. The campus also includes a medical research complex as well as research and education focused space.

The following is the list of scholars from Roswell Park Cancer Institute who currently serve as editors for one or more SciTechnol journals.

• Kailash C. Chadha, PhD

The following is the list of articles by scholars from Roswell Park Cancer Institute that are published in SciTechnol journals.

• Endometrioid Cancer Transform to Carcinosarcoma after Hormonal Treatment: Epithelial-Mesenchymal Transition during Fertility Preserving Management in Two Women

  Case Report: Clin Oncol Case Rep 2022, 5: 5 (229)
  DOI:
  Jie Yang, Huanwen Wu, Yang Xiang, Lingya Pan, and Jiaxin Yang
  
  • Abstract
  • Full-text
  • PDF

• Everolimus and Lenvatinib in a Kidney Metastatic Epithelioid Angiomyolipoma

  Case Report: Clin Oncol Case Rep 2022, 5: 5 (230)
  DOI:
  Flora Brouillard-Saby, Chahrazed Boukhatmi, Pierre Laurent-Puig, Laetitia Marisa, Nicolas Derive, Virginie Verkarre and Stephane Oudard
  
  • Abstract
  • Full-text
  • PDF

• Pseudocirrhosis in Metastatic Breast Cancer in a Male Successfully Treated with Leuprorelin and Anastrozole Followed by Eribulin: A Case Report

  Case Report: Clin Oncol Case Rep 2022, 5: 5 (231)
  DOI:
  Hafez Golzarian, Morgan Turnow, Alaha Mariam, Sidra R. Shah, Syed H. Haq, Benjamin A. Pasley, Christopher J. Hawkins, Rajpal Aujla and Joseph J. Sreenan
  
  • Abstract
  • Full-text
  • PDF

• Treatment-related myelodysplastic syndrome in a breast cancer survivor with TP53 mosaicism: the genetic dilemma

  Case Report: Clin Oncol Case Rep 2022, 5: 5 (232)
  DOI:
  Iuliia Kovalenko, Pooja Roy, Konstantin Golubykh, Tabinda Saleem and Kit Lu
  
  • Abstract
  • Full-text
  • PDF

• Cyclophosphamide, Bortezomib and Dexamethasone (CyBordD) for Multiple Extramedullary Plasmacytomas and Bilateral Myelomatous Pleural Effusion

  Case Report: Clin Oncol Case Rep 2022, 5: 5 (233)
  DOI:
  Leilei Teng, Jennifer R Hewlett, and Khalil I Hussein*
  
  • Abstract
  • Full-text
  • PDF

• Lacrimal Sac Diffuse Large B-Cell Lymphoma Presenting as Sudden Onset Binocular Diplopia: A Case Report

  Case Report: COCR
  DOI:
  Antoine Jeri-Yabar*, Bharati Dev, Marissa Patel Meihuan Lin
  
  • Abstract
  • Full-text
  • PDF

• Knowing Causes, Diagnosis, and Treatment Options for Lung Carcinoma

  Perspective: COCR
  DOI:
  Ravina Johns
  
  • Abstract
  • Full-text
  • PDF

• Understanding Lymph Node Dissection: Techniques, Indications, and Complications

  Perspective: COCR
  DOI:
  Geogeria Miller
  
  • Abstract
  • Full-text
  • PDF

• Advancements in Blood Tests: Revolutionizing Disease Detection and Monitoring

  Perspective: COCR
  DOI:
  Hiroyuki Aoki
  
  • Abstract
  • Full-text
  • PDF

• Unraveling the Complexities of Bladder Carcinoma: Understanding Pathogenesis, Diagnosis, and Treatment

  Perspective: COCR
  DOI:
  Nick Aglo
  
  • Abstract
  • Full-text
  • PDF